Determinants, outcomes and costs of ceftriaxone v. amoxicillin-clavulanate in the treatment of community-acquired pneumonia at Witbank Hospital
BACKGROUND: Community-acquired pneumonia (CAP) is a major cause of death and morbidity worldwide. Treatment is centred on antibiotics with ceftriaxone and amoxicillin-clavulanate being some of the most commonly prescribed agents. OBJECTIVE: To compare treatment outcomes and costs in patients receiving either of these two antibiotics at Witbank Hospital (WH). METHODS: A total of 200 randomly selected adult patient files (100 receiving ceftriaxone and 100 amoxicillin-clavulanate) recording a diagnosis of CAP were studied to determine the length of hospital stay, comorbid conditions and treatment outcomes. A descriptive and comparable analysis was performed. RESULTS: Male gender, higher CURB-65 scores and death were associated with the use of ceftriaxone. Severity of disease and previous antibiotic exposure influenced the duration of hospital admission. CONCLUSION: Gender and severity of disease (based on the CURB-65 score) were the determinants of antibiotic choice at WH. Male gender increased the likelihood of being treated with ceftriaxone, as did a CURB-65 score of >2. There were no differences in the outcomes of CAP patients treated with ceftriaxone compared with those treated with amoxicillin-clavulanate. Irrespective of antibiotic used, gender and severity of disease influenced treatment outcomes. Male gender was associated with a higher mortality and longer hospital stay. The average duration of stay for both antibiotics was not significantly different. Thus, only level 1 and 2 costs need to be considered when comparing the two regimens. On this basis, ceftriaxone was cheaper than amoxicillin-clavulanate.
Main Authors: | Xaba,S N, Greeff,O, Becker,P |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
South African Medical Association
2014
|
Online Access: | http://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S0256-95742014000300019 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gatifloxacin in the treatment of community-acquired pneumonias: a comparative trial of ceftriaxone, with or without macrolides, in hospitalized adult patients with mild to moderately severe pneumonia
by: Mendonça,J.S., et al.
Published: (2004) -
Recurrent drug-induced liver injury (DILI) with ciprofloxacin and amoxicillin/clavulanic
by: Moreno,Luís, et al.
Published: (2015) -
Recurrent cholestasis by amoxicillin-clavulanic acid: The importance of a correct diagnosis of hepatotoxicity
by: Sánchez-Ruiz-Granados,Elena, et al.
Published: (2012) -
Simultaneous determination of amoxicillin and clavulanic acid in pharmaceutical preparations by capillary zone electrophoresis
by: Hancu,Gabriel, et al.
Published: (2016) -
Intravenous azithromycin plus ceftriaxone followed by oral azithromycin for the treatment of inpatients with community-acquired pneumonia: an open-label, non-comparative multicenter trial
by: Rubio,Fernando G., et al.
Published: (2008)